 |
|
The article presents a comparative analysis of two initial public offerings (IPOs) currently open for subscription: Afcons Infrastructure and Godavari Biorefineries. While both companies represent significant players in their respective sectors, experts recommend subscribing to the Afcons Infrastructure IPO over the Godavari Biorefineries IPO, citing key factors that differentiate the two offerings.
Afcons Infrastructure, a leading infrastructure engineering and construction firm belonging to the Shapoorji Pallonji Group, is raising ₹5,430 crore through its IPO. The issue comprises a fresh share issue of ₹1,250 crore and an offer for sale (OFS) of up to ₹4,180 crore from promoter Goswami Infratech Private Ltd. Afcons intends to utilize the proceeds to acquire construction machinery, support working capital, pay down debt, and for general corporate purposes. The company’s price band has been set between ₹440-463 per share.
On the other hand, Godavari Biorefineries is seeking to raise ₹555 crore through its IPO, comprising a fresh equity share issue of ₹325 crore and an OFS of 65.27 lakh equity shares priced at ₹230 crore. The company plans to allocate the funds towards debt repayment and general corporate purposes. The price range for the offering is set between ₹334 and ₹352 per share.
Arun Kejriwal, founder of Kejriwal Research and Investment Services, highlights that both Afcons Infrastructure and Godavari Biorefineries are incomparable due to their distinct business models, scales, and financial performances. While Afcons boasts a strong track record of executing challenging engineering projects, such as the Atal Tunnel and the Chenab Railway Bridge, Godavari Biorefineries operates in a diversified business segment including bio-based chemicals, sugar, ethanol, and power. However, none of these segments dominates, and the bio-based chemicals derived from ethanol, while promising, will require significant time for scaling up.
Rajan Shinde, Research Analyst at Mehta Equities Ltd, emphasizes the potential of Afcons Infrastructure as an investment opportunity for investors. Shinde cites the company’s long history, diverse portfolio, strong order book, and enduring partnerships with reputable global clients as compelling factors. He points to Afcons’ operational excellence, demonstrated by consistent project completion ahead of schedule, as a key differentiator.
In contrast, Shinde does not recommend subscribing to Godavari Biorefineries, stating that the company lacks the compelling features that would warrant investment. While the company’s offerings in bio-based chemicals, sugar, ethanol, and power present potential, the lack of dominance in any specific segment and the need for scaling up certain businesses make it less attractive for investors.
In conclusion, based on the analysis and expert opinions presented in the article, Afcons Infrastructure emerges as the more favorable investment opportunity for investors. The company’s robust track record, strong order book, and diversified portfolio make it a compelling investment prospect. Godavari Biorefineries, while operating in a promising sector, lacks the compelling factors that would make it a suitable investment option at this stage.